Foxo stock forecast range for Q3 2024 stands at $0

FOXO stock forecast range for Q3 2024 stands at $0.18–$0.30 based on historical correlation with similar biotech micro-caps experiencing low liquidity but high announcement-driven volatility. That news caused shares to spike, and then they quickly returned to their former levels. Some investors would rightly characterize this as a pump and dump, something not uncommon in the world of penny stocks by any means. Additional information about the reverse stock split can be found in the Proxy Statement filed with the SEC and on the Company’s website at www.foxotechnologies.com/investors FOXO stock forecast models suggest potential upside if the company secures new strategic partnerships in health-data analytics. Current market cap remains under $5M, which often attracts high-risk, high-reward traders looking for micro-cap momentum in the biotech sector.